Upgrades •$Ardagh Metal(AMBP.US)$: Barclays Upgrades to Overweight from Equalweight - PT $9 •$美国运通(AXP.US)$: Edward Jones Upgrades to Buy from Hold •$CrowdStrike(CRWD.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $215 (from $195) •$Lululemon Athletica(LULU.US)$: Bernstein Upgrades to Market Perform from Underperform - PT $300 (from $260) •$瑞思迈(RMD.US)$: RBC Upgrades to Outperform from Sector Perform - PT $244 (from $...
Gainers: •$Okta(OKTA.US)$+15.8% (In reaction to earnings) •$StoneCo(STNE.US)$+12.9% (In reaction to earnings) •$Turning Point Therapeutics(TPTX.US)$+116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025) •$Amylyx Pharmaceuticals(AMLX.US)$+24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
$COMSovereign(COMS.US)$ComSovereign Scoops $8.4M Subcontract From US Government Prime Contractor $e家快服(EJH.US)$E-Home Household Service Holdings Limited Enters Into Two Separate Equity Acquisition Agreements To Acquire Significant Stakes In Household Appliance Service And Property Management Firms $Turning Point Therapeutics(TPTX.US)$Oppenheimer Maintains Outperform on Turning Point, Lowers Price Target to $105
Turning Point Therapeutics股票讨论区
专栏Top upgrades and downgrades on 6/6
• $Ardagh Metal(AMBP.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $9
• $美国运通(AXP.US)$ : Edward Jones Upgrades to Buy from Hold
• $CrowdStrike(CRWD.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $215 (from $195)
• $Lululemon Athletica(LULU.US)$ : Bernstein Upgrades to Market Perform from Underperform - PT $300 (from $260)
• $瑞思迈(RMD.US)$ : RBC Upgrades to Outperform from Sector Perform - PT $244 (from $...
专栏Today's pre-market stock movers: TSLA, CHGG, OKTA, TPTX and more
• $Okta(OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo(STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics(TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals(AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
专栏Top upgrades and downgrades on 5/20
• $智利银行(BCH.US)$ : Santander Upgrades to Outperform from Neutral - PT $25
• $联信银行(CMA.US)$ : Baird Upgrades to Outperform from Neutral - PT $85
• $Mirati Therapeutics(MRTX.US)$ : Guggenheim Upgrades to Buy from Neutral - PT $115
• $Ollie's Bargain Outlet(OLLI.US)$ : BofA Securities Upgrades to Buy from Underperform - PT $75 (from $39)
• $Trex Co.(TREX.US)$ : Exane Upgrades to Neutral from Underperform - PT $75
Downgrades
• $Ferguson(FERG.US)$ : Exane D...
$e家快服(EJH.US)$ E-Home Household Service Holdings Limited Enters Into Two Separate Equity Acquisition Agreements To Acquire Significant Stakes In Household Appliance Service And Property Management Firms
$Turning Point Therapeutics(TPTX.US)$ Oppenheimer Maintains Outperform on Turning Point, Lowers Price Target to $105
暂无评论